Haemonetics Reports 1st Quarter Fiscal 2016 Revenue of $213 Million and Adjusted EPS of $0.35, Reaffirms Full Fiscal Year Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. FDX
3. ABBV
4. MU
5. META
6. SPY
7. ACN
8. BLZE
9. IBM
10. NKE

Go back to Haemonetics Reports 1st Quarter Fiscal 2016 Revenue of $213 Million and Adjusted EPS of $0.35, Reaffirms Full Fiscal Year Guidance

Barrington Research Upgrades Haemonetics (HAE) to Outperform

July 28, 2015 8:10 AM EDT

Barrington Research upgraded Haemonetics (NYSE: HAE) from Market Perform to Outperform.

For an analyst ratings summary and ratings history on Haemonetics click here. For more ratings news on Haemonetics click here.

Shares of Haemonetics closed at $38.10 yesterday.

... More

Haemonetics (HAE) Tops Q1 EPS by 4c

July 27, 2015 6:08 AM EDT

Haemonetics (NYSE: HAE) reported Q1 EPS of $0.36, $0.04 better than the analyst estimate of $0.32. Revenue for the quarter came in at $213.4 million versus the consensus estimate of $215.62 million.

For earnings history and earnings-related data on Haemonetics (HAE) click here.

... More